Cetirizine fast dissolve tablet - Hyundai

Drug Profile

Cetirizine fast dissolve tablet - Hyundai

Alternative Names: Cetirizine fast dissolve tablet - Samyang

Latest Information Update: 30 Jun 2011

Price : $50

At a glance

  • Originator Hyundai Pharmaceutical; Samyang Group
  • Developer Hyundai Pharmaceutical
  • Class Acetic acids; Antiallergics; Nonsedating antihistamines; Piperazines; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Hypersensitivity

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top